Back to calendar
Rein Therapeutics, Inc. (RNTX) Earnings
RNTX reports earnings on Friday, November 6, 2026
earnings report
November 6, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.10
Actual EPS: $-0.10
EPS surprise: 41.18%
Company overview
Market Cap$65.7M
PriceUSD 0.76
EPS (TTM)-1.72
52-week high2.18
52-week low0.69
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees10